Krystal Biotech, Inc. KRYS Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s price / earnings?
- Krystal Biotech, Inc. (KRYS) reported price / earnings of 33.6× in Q1 2026.
- How has Krystal Biotech, Inc.'s price / earnings changed year-over-year?
- Krystal Biotech, Inc.'s price / earnings decreased by 19.9% year-over-year, from 41.9× to 33.6×.
- What is the long-term trend for Krystal Biotech, Inc.'s price / earnings?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s price / earnings has grown at a -67.0% compound annual growth rate (CAGR), from 319.7× to 34.9×.
- What does price / earnings mean?
- How many dollars investors pay for each dollar of the company's annual profit.
- How do you interpret price / earnings?
- Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
- How does price / earnings compare across companies?
- Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.